Gage Philip Jull

Executive

CA·SEDI

GeneTether Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 22 Mar 2022 for GeneTether Therapeutics Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Gage Philip Jull: trading record in brief

One trade, one date: on 22 March 2022, Gage Philip Jull disclosed a transaction in GeneTether Therapeutics Inc. No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to Gage Philip Jull

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

GeneTether Therapeutics Inc. (CA)

Declarations1 total

●

Gage Philip Jull

4 - Director of IssuerExecutives21 Mar 2022GeneTether Therapeutics Inc.

0SEDI

Common SharesTSXSEDI:3912091

1 of 1 declaration

Gage Philip Jull

Insider track record

Gage Philip Jull: trading record in brief

Companies and markets linked to Gage Philip Jull

Related entities

Gage Philip Jull

Insider track record

Gage Philip Jull: trading record in brief

Companies and markets linked to Gage Philip Jull

Related entities